Karen Haas to Macrophages
This is a "connection" page, showing publications Karen Haas has written about Macrophages.
Connection Strength
0.397
-
Dyevoich AM, Disher NS, Haro MA, Haas KM. A TLR4-TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells. Cancer Immunol Immunother. 2020 Oct; 69(10):2113-2124.
Score: 0.159
-
Dyevoich AM, Haas KM. Type I IFN, Ly6C+ cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination. Mol Cancer Ther. 2020 06; 19(6):1232-1242.
Score: 0.157
-
Minard-Colin V, Xiu Y, Poe JC, Horikawa M, Magro CM, Hamaguchi Y, Haas KM, Tedder TF. Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV. Blood. 2008 Aug 15; 112(4):1205-13.
Score: 0.069
-
Davis WC, Konzek RL, Haas K, Estes DM, Hamilton MJ, Call DR, Apostolopoulos V, McKenzie IF. Use of the mannan receptor to selectively target vaccine antigens for processing and antigen presentation through the MHC class I and class II pathways. Ann N Y Acad Sci. 2002 Oct; 969:119-25.
Score: 0.012